Exosomes Hair Treatment London: Hair Loss & Results Guide

Reviewed by Razvan Vasilas, DRV Clinic
Last reviewed: September 2026

Hair thinning rarely has one simple explanation.

Genetics, hormonal changes, illness, significant stress, rapid weight loss, nutritional deficiencies, medication and inflammatory scalp conditions can all influence hair growth or shedding. This is why identifying the likely cause matters before choosing an elective hair treatment.

Exosomes hair treatment has attracted considerable attention as a regenerative approach to thinning hair. Early human studies have reported encouraging changes in hair density and thickness, particularly in androgenetic alopecia, but the research remains relatively new. Products and treatment protocols also vary significantly.

For patients researching exosomes hair treatment london, the evidence therefore needs to be presented carefully.

Exosome-based treatment may be considered as a supportive non-surgical option for appropriately selected patients, but it should not be presented as guaranteed hair regrowth or as a replacement for investigating unexplained hair loss.

DRV Clinic offers hair-loss treatment at its Baker Street clinic in Marylebone, Central London.

Exosomes Hair Treatment at a Glance

What Are Exosomes?

Exosomes are extremely small extracellular vesicles released by cells. They carry biological material – including proteins, lipids and nucleic acids – that can participate in communication between cells.

Researchers have become interested in whether these signalling mechanisms could influence processes involved in tissue repair and hair-follicle activity.

This is the biological rationale behind exosome hair treatment.

However, the term “exosome treatment” covers a wide range of products and preparations.

Different preparations may have different cellular sources, manufacturing processes, concentrations, purification methods and biological contents. A commercial treatment marketed as containing exosomes should therefore not automatically be assumed to be identical to the preparations investigated in published clinical studies.

That distinction is important when evaluating claims about results.

What Does the Evidence Say About Exosomes and Hair Loss?

The evidence is encouraging, but it is still developing.

A 2025 systematic review examined 11 clinical studies investigating exosome-based interventions for alopecia. All included studies reported improvement in at least one hair-related parameter, with some reporting increases in hair density and thickness.

The authors also identified important limitations: relatively small studies, different exosome sources, varying protocols, inconsistent outcome measures and limited follow-up. They concluded that larger, better-standardised randomised controlled trials are still required.

Read the 2025 systematic review on PubMed

A further systematic review published in 2026 examined the expanding experimental and clinical evidence around exosomes for androgenetic alopecia. Early clinical studies reported improvements in hair density and shaft thickness, but the authors again highlighted small sample sizes, inconsistent measurements, limited controls, manufacturing differences and a lack of robust long-term evidence.

Read the 2026 systematic review on PubMed

So, does exosomes hair treatment work?

The most accurate answer is that early studies suggest potential benefit in selected patients, particularly those with pattern hair loss, but the treatment does not yet have the depth or standardisation of evidence available for established hair-loss therapies.

Promising is not the same as proven.

Which Type of Hair Loss Has Been Studied?

Much of the current interest in exosomes hair loss treatment relates to androgenetic alopecia.

This is commonly known as male or female pattern hair loss.

In androgenetic alopecia, genetically susceptible hair follicles gradually become smaller. The hairs they produce become progressively finer and shorter, eventually leading to visible thinning.

Several early clinical studies of exosome-based treatments have reported improvements in hair density or thickness in patients with androgenetic alopecia. However, the 2026 systematic review emphasises that clinical protocols remain inconsistent and that larger controlled trials are required before firm conclusions can be drawn.

The key point is that evidence relating to pattern hair loss should not automatically be applied to every other form of hair loss.

Why Should Hair Loss Be Assessed First?

Because different causes require different approaches.

Someone experiencing gradual genetic thinning is very different from someone who suddenly begins shedding after illness, pregnancy, rapid weight loss, nutritional deficiency or medication.

Likewise, patchy hair loss or an inflamed scalp may require medical or dermatological investigation rather than an elective regenerative treatment.

The NHS advises people to obtain an idea of what is causing their hair loss before attending a commercial hair clinic. It also notes that hair loss can be associated with conditions including illness, stress, weight loss and iron deficiency.

Read NHS guidance on hair loss

This is why DRV Clinic’s Hair Loss Treatment London guide discusses assessment as part of the treatment process.

Women with diffuse thinning can also read our dedicated Female Hair Loss Treatment London guide, which covers several possible causes of female hair loss in more detail.

Hair treatment should follow an understanding of the problem – not replace it.

Who May Be Suitable for Exosome Hair Treatment?

An elective hair exosome treatment may be considered in appropriately assessed patients with thinning hair who understand that the evidence is still developing.

Suitability depends on the pattern of hair loss, scalp condition, medical history, previous treatment and expectations.

Extra investigation may be appropriate when hair loss is sudden, rapidly progressing, patchy, associated with scalp inflammation, accompanied by other symptoms or potentially related to an underlying medical or nutritional issue.

Someone with longstanding pattern thinning and someone with sudden unexplained shedding should not automatically receive the same treatment.

How Is Exosome Hair Treatment Performed?

There is currently no universally established protocol.

Published studies have investigated different approaches, including scalp injections and techniques combining scalp procedures with topical application. Treatment intervals and exosome formulations have also varied.

That variability is one reason published research should not be interpreted as validating every commercial exosome hair treatment protocol.

Patients should be told what product is being used, how treatment will be delivered, why that protocol has been selected and what evidence is relevant to the specific approach.

How Many Exosome Hair Treatments Are Needed?

Semrush data show people frequently ask how many exosome treatments are needed for hair.

At present, there is no scientifically established number that applies to every patient.

Research studies have used different treatment schedules, and systematic reviews continue to identify protocol standardisation as an important gap in the evidence.

DRV Clinic currently offers Hair Loss Treatment with Exosomes as both a single session and a four-session course.

The existence of a four-session course does not mean that scientific evidence has established four sessions as the universal protocol.

The recommended approach should depend on the treatment being used, suitability and individual response.

When Could Hair Results Become Visible?

Hair grows slowly.

Even if a treatment influences follicle activity, meaningful changes in density or thickness cannot realistically be judged after several days.

Clinical hair-loss studies generally evaluate outcomes over weeks or months.

This is also why before-and-after photography needs to be standardised. Hair length, lighting, styling, wetness, camera distance and the direction in which the hair is brushed can substantially change how dense the scalp appears.

Where possible, consistent photography and objective measurements provide more useful information than casual phone photographs.

Is Exosome Hair Treatment Permanent?

There is currently insufficient evidence to claim that exosome hair treatment permanently reverses pattern hair loss.

Androgenetic alopecia is a progressive condition.

Even where a treatment improves hair density or thickness, the underlying biological tendency towards follicle miniaturisation may remain.

Long-term maintenance protocols for exosome-based hair treatment are also not yet standardised.

Claims of guaranteed permanent regrowth should therefore be treated cautiously.

What Are the Possible Risks?

Published clinical hair-loss studies have generally reported relatively limited short-term adverse effects, but the overall evidence base remains small compared with established therapies.

More importantly, safety cannot be assessed purely from the word “exosome”.

The source of the biological material, manufacturing process, purity, sterility, storage, formulation and route of administration may all affect the risk profile.

The 2026 systematic review specifically identifies manufacturing standardisation, scalability, regulatory frameworks and long-term safety and efficacy data as areas that still need development.

Patients should therefore understand the exact product and treatment protocol being proposed rather than assuming every product marketed as an exosome treatment has identical supporting evidence.

How Are Exosome Products Regulated in the UK?

This area needs careful wording.

The UK regulatory position of an individual product can depend on its composition, intended purpose, claims, mode of action and how it is supplied.

The MHRA determines whether products fall within categories such as medicinal products or medical devices. Its guidance specifically states that classification can depend on the claims made for a product and its mode of action.

Read MHRA guidance on borderline medicinal products

This general guidance should not be interpreted as confirmation that a specific commercial exosome product is MHRA-approved or authorised for hair-loss treatment.

Patients considering exosomes hair treatment london should therefore ask which exact product will be used and what regulatory documentation relates to that particular product.

Useful questions include the product name, manufacturer, biological source, method of administration and what human evidence relates specifically to the formulation being offered.

Exosome Hair Treatment vs Established Hair-Loss Treatments

Exosome therapy needs to be considered within the wider treatment landscape.

For androgenetic alopecia, established treatments include minoxidil and, for appropriate male patients, finasteride. The NHS identifies these as the main treatments for male pattern baldness and notes that minoxidil can also be used for female pattern hair loss. The NHS also makes clear that these treatments do not work for everyone and generally work only while they continue to be used.

Exosome-based treatment is different.

It is a developing regenerative approach with promising early research, but considerably less long-term and standardised clinical evidence.

This does not mean it has no role.

For appropriately selected patients who understand those limitations, an exosome-based scalp procedure may be considered as one of several non-surgical options.

Does Exosome Hair Treatment Work?

The answer is not a simple yes or no.

Early clinical research has reported increases in hair density and thickness in some patients receiving exosome-based treatments. Systematic reviews describe these findings as promising.

But the same reviews consistently identify limitations: small study populations, variable products, different treatment schedules, inconsistent measurements and limited long-term follow-up.

The evidence therefore supports continued clinical interest.

It does not support guaranteeing results.

Exosomes Hair Treatment Price at DRV Clinic

People searching exosomes hair treatment price or exosome hair treatment price often want to understand whether treatment is offered as a single procedure or a course.

DRV Clinic’s current live price list states:

View the current DRV Clinic treatment price list

Four individual £250 sessions would total £1,000, so the listed four-session course represents a £200 saving.

Price, however, should come after suitability.

A treatment package has little value if the patient’s hair loss requires a different investigation or treatment pathway.

What Should You Ask Before Booking Exosome Hair Treatment?

Before undergoing an exosomes hair loss treatment london procedure, it is reasonable to understand exactly what is being offered.

Ask what type of hair loss the practitioner believes is present, whether medical investigation should come first, what exact product will be used, where it comes from, how it will be administered, what human evidence relates to it, why a particular number of sessions is being recommended and how progress will be assessed.

You should also understand potential side effects, aftercare and what happens if there is little or no improvement.

Be cautious with guarantees.

Hair follicles do not read marketing claims.

Exosomes Hair Treatment at DRV Clinic London

DRV Clinic is located at 1st Floor, 136 Baker Street, London W1U 6UD, in Marylebone, Central London.

The clinic currently lists Hair Loss Treatment with Exosomes as a single-session treatment and as a four-session course.

For patients considering exosomes hair treatment london, consultation should consider the pattern and history of hair loss, previous treatments, scalp condition, expectations and whether further investigation is appropriate before treatment.

For appropriately selected patients who understand that exosome research is still evolving, treatment may be considered as a supportive non-surgical option.

The objective is not to promise new hair.

It is to identify the problem first, explain what the current science does – and does not – tell us, and then decide whether the treatment is reasonable for that individual.